The Pim1i‐treated 3xTg‐AD mice exhibited better performance in spatial reference and working memory than their non‐transgenic and vehicle‐treated counterparts through declines in phosphorylated PRAS40 levels as well as Aβ reduction.65 This evidence concerns the gene AKT1S1 and Alzheimer disease.